Endothelial Nitric Oxide Synthase Polymorphism (−786T→C) and Increased Risk of Angiographic Vasospasm After Aneurysmal Subarachnoid Hemorrhage
- 1 April 2008
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 39 (4) , 1103-1108
Abstract
Background and Purpose— Vasospasm after aneurysmal subarachnoid hemorrhage (SAH) remains a leading cause of death and disability after aneurysm rupture. Decreased availability of nitric oxide (NO) may be crucial in its pathogenesis. We hypothesized that endothelial NO synthase ( eNOS ) polymorphisms may determine susceptibility to vasospasm in SAH patients. Methods— We conducted a prospective cohort study of SAH patients and determined vasospasm by cerebral angiography. We genotyped 3 eNOS polymorphisms: an intron 4 variable-number tandem-repeat, a promoter single-nucleotide polymorphism (−786T→C SNP), and a coding SNP in exon 7 (894G→T encoding E298D). Using multivariable logistic regression, we quantified the association of eNOS polymorphisms in patients with vasospasm confirmed by cerebral angiography. Results— For the eNOS promoter −786T→C SNP, the presence of the CC genotype compared with any T genotype ( CT or TT ) was associated with increased odds of vasospasm (odds ratio=2.97, 95% CI=1.32 to 6.67, P =0.008). No association with vasospasm was observed for the eNOS 894G→T or variable-number tandem-repeat polymorphisms. Conclusions— These findings suggest that genetic variation influencing NO regulation contributes to the risk of angiographic vasospasm in patients with SAH. The specific role of the promoter SNP (−786T→C) may determine the effect of NO regulated by this pathway, distinct from other known eNOS polymorphisms.Keywords
This publication has 50 references indexed in Scilit:
- Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter Phase IIa studyJournal of Neurosurgery, 2005
- Reduction of ischemic sequelae following spontaneous subarachnoid hemorrhage: a double-blind, randomized comparison of enoxaparin versus placeboClinical Neurology and Neurosurgery, 2004
- Cerebral vasospasm after subarachnoid hemorrhageCurrent Opinion in Critical Care, 2003
- Genetic Risk Factors for Coronary Artery Spasm: Significance of Endothelial Nitric Oxide Synthase Gene T −786 →C and Missense Glu298Asp VariantsJournal of Investigative Medicine, 2000
- Decreased Nitric Oxide Availability Contributes to Acute Cerebral Ischemia after Subarachnoid HemorrhageNeurosurgery, 2000
- T−786→C Mutation in the 5′-Flanking Region of the Endothelial Nitric Oxide Synthase Gene Is Associated With Coronary SpasmCirculation, 1999
- Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part I. A cooperative study in Europe, Australia, New Zealand, and South AfricaJournal of Neurosurgery, 1999
- A smoking–dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase geneNature Medicine, 1996
- Cerebral Arterial Spasm – A Controlled Trial of Nimodipine in Patients with Subarachnoid HemorrhageNew England Journal of Medicine, 1983
- Surgical Risk as Related to Time of Intervention in the Repair of Intracranial AneurysmsJournal of Neurosurgery, 1968